Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vivo Bio TechBOM:511509 -0.17%64 Days Inventory is 400.75 as of Jun. 2026, which is 4% above its 10-year median of 384.83. GuruFocus rates BOM:511509 with a GF Score™ of 64/100 and a GF Value™ of ₹30.49 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 638 Biotechnology companies, Vivo Bio Tech ranks worse than 72.73% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vivo Bio Tech's Average Total Inventories for the
three
months ended in Jun. 2026 was ₹81.5 Mil. Vivo Bio Tech's Cost of Goods Sold for the
three
months ended in Jun. 2026 was ₹18.6 Mil.
Hence, Vivo Bio Tech's Days Inventory for the
three
months ended in Jun. 2026 was 400.75.
The historical rank and industry rank for Vivo Bio Tech's Days Inventory or its related term are showing as below:
BOM:511509'
s Days Inventory Range Over the Past 10 Years
Min: 193.62 Med: 384.83 Max: 793.9
Current: 328.29
During the past 13 years, Vivo Bio Tech's highest Days Inventory was 793.90. The lowest was 193.62. And the median was 384.83.
BOM:511509's Days Inventory is ranked worse than 72.73% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs BOM:511509: 328.29
Vivo Bio Tech's Days Inventory
declined
from Jun. 2025 (472.00) to Jun. 2026 (400.75).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vivo Bio Tech's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vivo Bio Tech's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.57.
Vivo Bio Tech (BOM:511509) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vivo Bio Tech's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vivo Bio Tech's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vivo Bio Tech Days Inventory Related Terms
Vivo Bio Tech Days Inventory Historical Data
* Premium members only.
The historical data trend for Vivo Bio Tech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:511509 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Vivo Bio Tech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivo Bio Tech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vivo Bio Tech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivo Bio Tech (BOM:511509) has a Days Inventory of 400.75 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vivo Bio Tech and its competitors. This is near median its historical median of 384.83. Over the past decade, Vivo Bio Tech's Days Inventory has ranged from 193.62 to 793.90. According to the industry distribution chart, Vivo Bio Tech ranks #464 out of 638 companies in the Biotechnology industry, placing it in the top 72.7%.
Is Vivo Bio Tech's Days Inventory too high?
Vivo Bio Tech's current Days Inventory of 400.75 is near median its 10-year median of 384.83. Over the past 10 years, this metric has ranged from a low of 193.62 to a high of 793.90. The Biotechnology industry median Days Inventory is 183.20. Vivo Bio Tech's value of 400.75 is 118.8% above this industry median. Based on the distribution chart, Vivo Bio Tech ranks #464 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Vivo Bio Tech has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vivo Bio Tech's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Vivo Bio Tech ranks #464 out of 638 companies for Days Inventory. This places Vivo Bio Tech in the lower half of its industry. The industry median Days Inventory is 183.20. Vivo Bio Tech's value of 400.75 is 118.8% above this benchmark. Historically, Vivo Bio Tech's own Days Inventory has ranged from 193.62 to 793.90 over the past decade. While the company's 10-year median is 384.83 vs. the industry median of 183.20, Vivo Bio Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vivo Bio Tech's current Days Inventory of 400.75 is 118.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vivo Bio Tech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vivo Bio Tech's current Days Inventory is 400.75, which is near median its own 10-year median of 384.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivo Bio Tech stock overvalued right now?
Based on GuruFocus' analysis, Vivo Bio Tech (BOM:511509) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹30.49, compared to a current price of ₹23.37 — trading 23.4% below its estimated fair value. The current Days Inventory is 400.75, which is near median its 10-year median of 384.83 and 118.8% above the Biotechnology industry median of 183.20. Vivo Bio Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vivo Bio Tech (BOM:511509), the current Days Inventory is 400.75 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vivo Bio Tech (BOM:511509) Overvalued in 2026?
Based on GuruFocus' analysis, Vivo Bio Tech stock appears to be undervalued.
The current stock price of ₹23.37 is trading 23.4% below its estimated GF Value™ of ₹30.49.
GuruFocus considers Vivo Bio Tech to be Modestly Undervalued.
Key valuation signals for BOM:511509:
Days Inventory: 400.75 (near median its 10-year median of 384.83)
GF Value™: ₹30.49 vs. price of ₹23.37 (23.4% below fair value)
Industry Position: 118.8% above the Biotechnology median (#464 of 638)
No single metric tells the full story. See the BOM:511509 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.
64GF Score
Get the complete analysis for BOM:511509
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:511509 has been successfully added to your 
